Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
746.36
-6.26 (-0.83%)
Dec 16, 2025, 4:00 PM EST - Market closed
Regeneron Pharmaceuticals Analyst Ratings
Total Analysts
23
Consensus Rating
Buy
Price Target
$795.74
Upside
+6.62%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $767 → $768 | Hold | Maintains | $767 → $768 | +2.90% | Dec 12, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $700 → $745 | Hold | Maintains | $700 → $745 | -0.18% | Dec 10, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $850 → $1,057 | Strong Buy | Maintains | $850 → $1,057 | +41.62% | Dec 4, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $725 → $850 | Buy | Maintains | $725 → $850 | +13.89% | Dec 4, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $767 | Buy → Hold | Downgrades | $767 | +2.77% | Dec 3, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $812 → $798 | Strong Buy | Initiates | $812 → $798 | +6.92% | Nov 24, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $650 → $770 | Hold | Maintains | $650 → $770 | +3.17% | Nov 24, 2025 |
| HSBC | HSBC | Strong Buy Initiates $890 | Strong Buy | Initiates | $890 | +19.25% | Nov 24, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $615 → $700 | Hold | Maintains | $615 → $700 | -6.21% | Nov 20, 2025 |
| UBS | UBS | Hold Maintains $595 → $660 | Hold | Maintains | $595 → $660 | -11.57% | Nov 7, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $660 → $700 | Strong Buy | Maintains | $660 → $700 | -6.21% | Oct 29, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $704 → $708 | Hold | Maintains | $704 → $708 | -5.14% | Oct 29, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $580 → $615 | Hold | Maintains | $580 → $615 | -17.60% | Oct 29, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $678 → $740 | Buy | Maintains | $678 → $740 | -0.85% | Oct 29, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $815 → $865 | Strong Buy | Maintains | $815 → $865 | +15.90% | Oct 29, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $543 → $627 | Sell | Maintains | $543 → $627 | -15.99% | Oct 29, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.